SARAH STORR sarah.storr@nottingham.ac.uk
Assistant Professor
Calpain system protein expression in basal-like and
triple-negative invasive breast cancer
Storr, Sarah J.; Lee, K.W.; Woolston, Caroline M.; Safuan, Sabreena; Green, A.R.; Macmillan, R.D.; Benhasouna, A.; Parr, T.; Ellis, I.O.; Martin, Stewart G.
Authors
K.W. Lee
Caroline M. Woolston
Sabreena Safuan
A.R. Green
R.D. Macmillan
A. Benhasouna
T. Parr
I.O. Ellis
Stewart G. Martin
Abstract
Background: Basal-like and triple-negative breast tumours encompass an important clinical subgroup and
biomarkers that can prognostically stratify these patients are required.
Materials and methods: We investigated two breast cancer tissue microarrays for the expression of calpain-1,
calpain-2 and calpastatin using immunohistochemistry. The first microarray was comprised of invasive tumours from
1371 unselected patients, and the verification microarray was comprised of invasive tumours from 387 oestrogen
receptor (ER)-negative patients.
Results: The calpain system contains a number of proteases and an endogenous inhibitor, calpastatin. Calpain activity
is implicated in important cellular processes including cytoskeletal remodelling, apoptosis and survival. Our results show
that the expression of calpastatin and calpain-1 are significantly associated with various clinicopathological criteria
including tumour grade and ER expression. High expression of calpain-2 in basal-like or triple-negative disease was
associated with adverse breast cancer-specific survival (P = 0.003 and <0.001, respectively) and was verified in an
independent cohort of patients. Interestingly, those patients with basal-like or triple-negative disease with a low level of
calpain-2 expression had similar breast cancer-specific survival to non-basal- or receptor- (oestrogen, progesterone or
human epidermal growth factor receptor 2 (HER2)) positive disease.
Conclusions: Expression of the large catalytic subunit of m-calpain (calpain-2) is significantly associated with clinical
outcome of patients with triple-negative and basal-like disease.
Citation
triple-negative invasive breast cancer. Annals of Oncology, 23(9), https://doi.org/10.1093/annonc/mds176
Journal Article Type | Article |
---|---|
Publication Date | Sep 9, 2012 |
Deposit Date | Apr 1, 2014 |
Publicly Available Date | Apr 1, 2014 |
Journal | Annals of Oncology |
Print ISSN | 0923-7534 |
Electronic ISSN | 1569-8041 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 23 |
Issue | 9 |
DOI | https://doi.org/10.1093/annonc/mds176 |
Public URL | https://nottingham-repository.worktribe.com/output/711522 |
Publisher URL | http://annonc.oxfordjournals.org/content/23/9/2289.full |
Files
Martin_Calpain_system.pdf
(300 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc/4.0
You might also like
High BMP7 expression is associated with poor prognosis in ovarian cancer
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search